Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A1 | P22736 | 1/20 | 0.57 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.57 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.55 |
| ▸ | PLK1 | P53350 | 1/20 | 0.55 |
| ▸ | MMP3 | P08254 | 1/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.52 |
| ▸ | CDC25B | P30305 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | GMNN | O75496 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6622009 | 0.86 | NR4A1 (0.44) | NR4A1NR4A2NR4A3PTPN1PLK1 | |
| SCHEMBL4109121 | 0.85 | NR4A1 (0.53) | NR4A1NR4A2NR4A3PTPN1PLK1 | |
| SCHEMBL5716814 | 0.84 | NR4A1 (0.61) | NR4A1NR4A2NR4A3PTPN1PLK1 | |
| SCHEMBL32665708 | 0.84 | NR4A1 (0.61) | NR4A1NR4A2NR4A3PTPN1PLK1 | |
| SCHEMBL2599098 | 0.82 | NR4A1 (0.59) | NR4A1NR4A2NR4A3PTPN1PLK1 | |
| SCHEMBL2599103 | 0.82 | NR4A1 (0.59) | NR4A1NR4A2NR4A3PTPN1PLK1 | |
| SCHEMBL25057402 | 0.81 | NR4A1 (0.57) | NR4A1NR4A2NR4A3PTPN1PLK1 | |
| SCHEMBL10358074 | 0.81 | NR4A1 (0.57) | NR4A1NR4A2NR4A3PTPN1PLK1 | |
| SCHEMBL6008119 | 0.81 | NR4A1 (0.57) | NR4A1NR4A2NR4A3PTPN1PLK1 | |
| SCHEMBL5125965 | 0.81 | NR4A1 (0.57) | NR4A1NR4A2NR4A3PTPN1PLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10398028-B2 | Surface treating composition for copper and copper alloy and utilization thereof | SHIKOKU CHEMICALS CORPORATION (JP) | 2019-08-27 | — | — | US | disclosed |
| US-20170064823-A1 | SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF | SHIKOKU CHEMICALS CORPORATION (JP) | 2017-03-02 | — | — | US | disclosed |
| US-9532493-B2 | Surface treating composition for copper and copper alloy and utilization thereof | SHIKOKU CHEMICALS CORPORATION (JP) | 2016-12-27 | — | — | US | disclosed |
| EP-2714962-B1 | SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF | SHIKOKU CHEM (JP) | 2015-07-08 | — | — | EP | disclosed |
| US-20140097231-A1 | SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF | SHIKOKU CHEMICALS CORPORATION (JP) | 2014-04-10 | — | — | US | disclosed |
| US-8378116-B2 | Phenylnaphthylimidazole compound and usage of the same | SHIKOKU CHEMICALS CORPORATION (JP) | 2013-02-19 | — | — | US | disclosed |
| EP-1753728-B1 | PHENYLNAPHTHYLIMIDAZOLES FOR USE ON COPPER SURFACES DURING SOLDERING | SHIKOKU CHEM (JP) | 2012-12-19 | — | — | EP | disclosed |
| US-20120199385-A1 | PHENYLNAPHTHYLIMIDAZOLE COMPOUND AND USAGE OF THE SAME | SHIKOKU CHEMICALS CORPORATION (JP) | 2012-08-09 | — | — | US | disclosed |
| US-8183386-B2 | Phenylnaphthylimidazole compound and usage of the same | SHIKOKU CHEMICALS CORPORATION (JP) | 2012-05-22 | — | — | US | disclosed |
| US-20090221645-A1 | Dihydroimidazothiazole Derivatives | PROSIDION LIMITED (GB) | 2009-09-03 | — | — | US | disclosed |
| EP-1474141-A1 | 5-HT2B RECEPTOR ANTAGONISTS | Pharmagene Laboratories Ltd (GB) | 2004-11-10 | — | — | EP | disclosed |
| US-20040010022-A1 | 5-HT2B receptor antagonists | ASTERAND, INC. | 2004-01-15 | — | — | US | disclosed |
| WO-2003068227-A1 | 5-HT2B RECEPTOR ANTAGONISTS | PHARMAGENE LABORATORIES LIMITED (GB) | 2003-08-21 | — | — | WO | disclosed |
| WO-2003068226-A1 | 2-OXAZOLAMINES AND THEIR USE AS 5-HT2B RECEPTOR ANTAGONISTS | PHARMAGENE LABORATORIES LIMITED (GB) | 2003-08-21 | — | — | WO | disclosed |
| EP-0576350-B1 | Branched alkylamino thiazole derivatives, process for their preparation and pharmaceutical compositions containing them | SANOFI SA (FR) | 1997-10-29 | — | — | EP | disclosed |
| US-5464847-A | Moduators of corticotropin releasing factor | ELF SANOFI (FR) | 1995-11-07 | — | — | US | disclosed |
| EP-0576350-A1 | Branched alkylamino thiozole derivatives, process for their preparation and pharmaceutical compositions containing them | SANOFI (FR) | 1993-12-29 | — | — | EP | disclosed |
| EP-0284297-B1 | HALOGENATED NAPHTHALENE DERIVATIVES | NIPPON OIL CO. LTD. (JP) | 1990-12-27 | — | — | EP | disclosed |
| US-4803013-A | IMPROVED DIELECTRIC PROPERTIES, HYDROGEN ABSORPTION, FLUIDITY, VISCOSITY STABILITY | NIPPON OIL CO., LTD. (JP) | 1989-02-07 | — | — | US | disclosed |
| EP-0284297-A1 | Halogenated Naphthalene Derivatives | NIPPON OIL CO. LTD. (JP) | 1988-09-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090221645-A1 | Dihydroimidazothiazole Derivatives | TPH1, HTR3B, HTR1A | NR4A1 498/4885NR4A2 544/4885NR4A3 463/4885 |
| US-10398028-B2 | Surface treating composition for copper and copper alloy and utilization thereof | SOD1, SOD3, AOC3 | NR4A1 3115/4885NR4A2 3553/4885NR4A3 3259/4885 |
| US-20040010022-A1 | 5-HT2B receptor antagonists | HTR2B, HTR1B, HTR2C | NR4A1 121/4885NR4A2 205/4885NR4A3 214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.